Johan Frieling

Johan Frieling serves as the Chief Medical Officer at AUROBAC THERAPEUTICS, focusing on the clinical development of innovative precision medicine products targeting bacterial infections and sepsis. With extensive experience in the pharmaceutical industry, Johan has held prominent positions such as Chief Medical Officer at MICREOS, where contributions included developing alternatives to antibiotics. Previous roles encompass Director of Clinical Research at LFB and Vice President of Clinical Development at LFB USA, Inc., emphasizing global clinical strategies. Additionally, Johan is active in volunteer roles, including Treasurer and Chairman at Stichting Kinderdroomwens and Secretary at KwaKbergband. Johan's educational background includes a PhD in Medicine and an MD from Radboud University.